| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Vaxcyte, Inc.'s insiders have reduced their positions by a net 45,442 shares worth roughly $3.7M.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 429.9K | $26.14M | - | |
| COO | 145.4K | $8.84M | - | |
| CFO | 95.3K | $5.80M | - | |
| Other | 68.1K | $4.14M | - | |
| Other | 52.6K | $3.20M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 1, 2024 | Jim Wassil53 | Chief Operating Officer | Sell10b5-1 | 3,000 | $66.69 | $200,065.55 | -1.4% | +15.3% | -51.7% | |
| Apr 1, 2024 | Grant Pickering50 | Chief Executive Officer | Sell10b5-1 | 2,616 | $66.71 | $174,501.51 | -1.7% | +15.3% | -51.7% | |
| Mar 25, 2024 | Grant Pickering50 | Chief Executive Officer | Sale+OE10b5-1 | 15,000 | $66.93 | $1,003,978.40 | -3.0% | +14.2% | +8.3% | |
| Mar 18, 2024 | Andrew Guggenhime46 | President and CFO | Sale+OE10b5-1 | 8,000 | $69.02 | $552,143.75 | -7.7% | +5.6% | +9.8% | |
| Mar 1, 2024 | Jim Wassil53 | Chief Operating Officer | Sell10b5-1 | 3,000 | $73.71 | $221,133.89 | -1.3% | -2.1% | +1.8% | |
| Mar 1, 2024 | Elvia Cowan71 | SVP, Finance | Sale+OE10b5-1 | 11,678 | $74.08 | $865,070.44 | -48.3% | -2.1% | +1.8% | |
| Mar 1, 2024 | Mikhail Eydelman67 | SVP, Gen Counsel & Corp Sec | Sale+OE10b5-1 | 1,667 | $73.73 | $122,906.84 | -5.1% | -2.1% | +1.8% | |
| Mar 1, 2024 | Grant Pickering50 | Chief Executive Officer | Sell10b5-1 | 2,616 | $73.70 | $192,799.23 | -1.7% | -2.1% | +1.8% | |
| Feb 26, 2024 | Grant Pickering50 | Chief Executive Officer | Sale+OE10b5-1 | 45,000 | $78.09 | $3,514,106.06 | -10.7% | -13.0% | +0.5% | |
| Feb 20, 2024 | Andrew Guggenhime46 | President and CFO | Sale+OE10b5-1 | 8,000 | $74.53 | $596,231.64 | -9.1% | +2.5% | +12.5% |